Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Prevalence and Risk Factors of Retinopathy of Prematurity in Iran Publisher



Zarei M1 ; Bazvand F1 ; Ebrahimiadib N1 ; Roohipoor R1 ; Karkhaneh R1 ; Dastjani AF1 ; Fouladi MI1 ; Esfahani MR1, 2 ; Khodabande A1 ; Davoudi S3 ; Ghasemi H1 ; Modjtahedi BS4
Authors

Source: Journal of Ophthalmic and Vision Research Published:2019


Abstract

Purpose: The present study aimed to evaluate the frequency and risk factors of retinopathy of prematurity (ROP) among Iranian infants. Methods: A retrospective cohort study was conducted on infants who had undergone screening for ROP at Farabi Eye Hospital, between March 2016 and March 2017. Data were analyzed based on the presence of extreme prematurity (gestational age ≤28 weeks), extremely low-birth-weight (≤1000 g), and multiplegestation (MG) infants. Results: The prevalence of ROP was 27.28% (n = 543) among all screened infants, 74.4% for extremely preterm (EP) infants, 77.5% for extremely low birth weight (ELBW) babies, and 27.25% for infants from MG pregnancies. On multivariate analysis, gestational age, birth weight, and history of transfusion (P < 0.0001, P < 0.0001, and P = 0.04, respectively) were found to be significantly associated with ROP. More advanced stages of ROP (P < 0.0001) were observed in EP and ELBW infants. Birth weight (P = 0.088), history of transfusion (P = 0.066), and intubation (P = 0.053) were not associated with increased risk of ROP in EP infants, while gestational age (P = 0.037) and history of transfusion (P = 0.040) were significant risk factors for ROP in ELBW infants. Gestational age (P < 0.001) and birth weight (P = 0.001) were significantly associated with ROP in infants from MG pregnancies in multivariate analysis. Conclusion: ROP remains a commonly encountered disease, especially in ELBW and EP infants. The history of transfusion may have a role in stratifying the risk for ROP and guiding future screening guidelines. © 2019 Journal of opthalmic and vision research.
Other Related Docs
4. Validation of the Postnatal Growth and Retinopathy of Prematurity (G-Rop) Screening Criteria, Medical Hypothesis# Discovery# and Innovation in Ophthalmology (2022)
20. A Review on Retinopathy of Prematurity, Medical Hypothesis, Discovery, and Innovation in Ophthalmology (2024)